When the Gradient Falls, Do Symptoms Follow? Understanding the impact of Myosin Inhibitors on Patient Reported Outcomes.

O'Hara M, Sciamanna C, Kim GH, Narang N

Open source

DOI
10.1016/j.cardfail.2026.08.025
Published
2026 Sep 10
Container
Journal of cardiac failure
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cardfail.2026.08.025,
  title = {When the Gradient Falls, Do Symptoms Follow? Understanding the impact of Myosin Inhibitors on Patient Reported Outcomes.},
  author = {O'Hara M and Sciamanna C and Kim GH and Narang N},
  year = {2026},
  journal = {Journal of cardiac failure},
  doi = {10.1016/j.cardfail.2026.08.025},
  url = {https://doi.org/10.1016/j.cardfail.2026.08.025}
}

RIS

TY  - JOUR
TI  - When the Gradient Falls, Do Symptoms Follow? Understanding the impact of Myosin Inhibitors on Patient Reported Outcomes.
AU  - O'Hara M
AU  - Sciamanna C
AU  - Kim GH
AU  - Narang N
PY  - 2026
JO  - Journal of cardiac failure
DO  - 10.1016/j.cardfail.2026.08.025
UR  - https://doi.org/10.1016/j.cardfail.2026.08.025
ER  - 

APA

M, O., C, S., GH, K., & N, N. (2026). When the Gradient Falls, Do Symptoms Follow? Understanding the impact of Myosin Inhibitors on Patient Reported Outcomes.. Journal of cardiac failure. https://doi.org/10.1016/j.cardfail.2026.08.025

Source records